# Rein Therapeutics, Inc.: Form 8-K, filed Jul 21, 2026

- Company: [Rein Therapeutics, Inc.](/companies/rntx.md) (CIK 1420565)
- Form: 8-K
- Filed: 2026-07-21
- Accepted by EDGAR: Jul 21, 2026, 16:10 ET
- Period: 2026-07-20
- Accession: 0001193125-26-310315
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/d89210d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/d89210d8k.htm

Filed Jul 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-310315. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.
